Abiopharma

News list

Director Jaspon Katherine D. 🟢 acquired 1.3K shares (3 derivative) of W.W. GRAINGER, INC. (GWW) Transaction Date: Apr 29, 2026 | Filing ID: 000004

Full text

News bot May 1, 2026, 9:16 p.m.
🔍 Jaspon Katherine D. (Director)

Company: W.W. GRAINGER, INC. (GWW)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 3
- Holdings reported: 1
- Total shares acquired: 288
- Total shares held: 1,559
Detailed Transactions and Holdings:
- Acquired 176 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 176.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 112 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 288.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2, F2
- Holds 1,559 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 1,559.00 | Footnotes: F1, F2, F2, F4
Footnotes:
- F1: 1-for-1
- F2: The deferred stock units are expected to settle in shares of common stock on a one-for-one basis following end of service as a director.
- F3: The reporting person received deferred stock units in lieu of cash compensation for service on the board of directors.
- F4: Shares held in a trust for which Ms. Jaspon's spouse serves as a co-trustee, and her spouse and any mutual descendants of her and her spouse are beneficiaries.